Imperial College London Featured PhD Programmes
University of Glasgow Featured PhD Programmes
University of Exeter Featured PhD Programmes
University of Portsmouth Featured PhD Programmes
Coventry University Featured PhD Programmes
"recombinant"×
10 miles

Medical / Clinical Science (recombinant) PhD Projects, Programs & Scholarships

We have 5 Medical / Clinical Science (recombinant) PhD Projects, Programs & Scholarships

  • "recombinant" ×
  • Medical / Clinical Science×
  • clear all
Order by 
Showing 1 to 5 of 5
  Mini Centre for Doctoral Training: Overcoming drug-resistant microbial infection – Targeting the power of Molecular Machines
  Dr E Main, Prof RW Pickersgill, Dr V Darbari, Dr A Kang
Application Deadline: 31 January 2020

Funding Type

PhD Type

The newly formed “Centre for Structural Medicine” (joint between the Schools of Biological and Chemical Sciences and Medicine and Dentistry) is seeking PhD applicants for their fully funded mini Centre for Doctoral Training (CDT) to start in September 2020.
  PhD in Cancer Virotherapies - Development of precision virotherapies capable of evading anti-vector immunity.
  Dr A Parker, Prof A Gallimore
Application Deadline: 14 February 2020

Funding Type

PhD Type

The use of “oncolytic” viruses has immense potential in the cancer setting where the therapeutic self-amplifies, through replication, at the site of need (i.e.
  PhD in Cancer Virotherapies - Novel strategies for developing tumour selective virotherapies.
  Dr A Parker, Prof P Rizkallah
Application Deadline: 14 February 2020

Funding Type

PhD Type

The use of “oncolytic” viruses has immense potential in the cancer setting where the therapeutic self-amplifies, through replication, at the site of need (i.e.
  Evolutionary insights for engineering improved globin oxygen carriers
  Dr M Berenbrink, Dr J Madine
Applications accepted all year round

Funding Type

PhD Type

Around 2 million red blood cell units at a cost of 120.00 GBP per unit are transfused annually in England alone (http://www.nhsbt.nhs.uk/what-we-do/blood-transfusion/).
  Bispecific monoclonal antibodies for cancer immunotherapy
  Prof W Bodmer, Prof P McHugh
Application Deadline: 3 March 2020

Funding Type

PhD Type

THE PROJECT. Monoclonal antibodies (MCAs) are now widely used for cancer therapy. DNA recombinant technology enables the production of MCAs that target cancer specific determinants and immune cells, attracting them to the cancer cells and so killing them.
Show 10 15 30 per page
  • 1


FindAPhD. Copyright 2005-2020
All rights reserved.